<- Go Home
Inogen, Inc.
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
Market Cap
$191.8M
Volume
232.9K
Cash and Equivalents
$93.1M
EBITDA
-$9.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$155.8M
Profit Margin
44.31%
52 Week High
$9.13
52 Week Low
$5.34
Dividend
N/A
Price / Book Value
1.05
Price / Earnings
-7.65
Price / Tangible Book Value
1.34
Enterprise Value
$98.6M
Enterprise Value / EBITDA
-16.87
Operating Income
-$30.1M
Return on Equity
13.07%
Return on Assets
-6.33
Cash and Short Term Investments
$110.2M
Debt
$16.9M
Equity
$182.9M
Revenue
$351.5M
Unlevered FCF
-$3.0M
Sector
Health Care Equipment and Supplies
Category
N/A